“Pharmaceutical care directed to patients with rheumatoid arthritis and systemic lupus erythematosus: survey of a pharmacotherapeutic profile” (2022) Research, Society and Development, 11(16), p. e203111638026. doi:10.33448/rsd-v11i16.38026.